ZNTL
Zentalis Pharmaceuticals, Inc.
-0.02 (-0.65%)3.08USD440K成交股數221M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00 | 0.00 | 0.00-100% | 0.00 | 0.00 | 0.00 | 40.6M | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 35.2M | 28.7M | 29.5M | 23.0M | 27.6M | 27.2M | 36.8M | 48.4M | 49.6M | 51.6M | 46.8M | 42.7M |
| 銷售管理費用 | 9.2M | 9.1M | 7.9M | 10.8M | 8.4M | 10.6M | 14.6M | 16.8M | 15.7M | 16.4M | 16.0M | 15.7M |
| 營業利益 | −44.4M+23% | −37.9M-17% | −37.4M-27% | −33.7M-48% | −36.1M+46% | −45.6M-33% | −51.4M-18% | −65.1M-37% | −24.8M | −67.9M | −62.7M | −104M |
| 營業利益率 | – | – | – | – | – | – | – | – | -61.1% | – | – | – |
| 稅後淨利 | −42.3M+57% | −35.4M-27% | −35.2M-12% | −26.7M-70% | −26.9M-367% | −48.3M-21% | −40.2M-28% | −88.3M-22% | 10.1M | −61.0M | −55.5M | −113M |
| 淨利率 | – | – | – | – | – | – | – | – | 24.8% | – | – | – |
| 稀釋 EPS | -0.59+59% | -0.50-25% | -0.50-11% | -0.37-70% | -0.37-364% | -0.67-12% | -0.56-29% | -1.24-33% | 0.14 | -0.76 | -0.79 | -1.85 |
| 稀釋股數 | 71.3M | 70.3M | 71.9M | 72.1M | 72.0M | 71.7M | 71.1M | 71.0M | 71.2M | 65.4M | 70.6M | 60.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.8M | 31.9M | 36.0M | 39.1M | 37.6M | 41.9M | 41.3M | 37.0M | 37.6M | 28.0M | 111M | 267M |
| 應收帳款 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | 0.00 | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 215M | 253M | 289M | 327M | 352M | 384M | 451M | 492M | 557M | 552M | 586M | 621M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 71.7M | 70.4M | 72.8M | 74.4M | 77.2M | 88.6M | 96.3M | 109M | 98.7M | 114M | 104M | 98.2M |
| 股東權益 | 144M | 183M | 216M | 253M | 274M | 295M | 354M | 383M | 459M | 437M | 482M | 523M |
| 負債比 | 33.3% | 27.8% | 25.2% | 22.7% | 22.0% | 23.1% | 21.4% | 22.2% | 17.7% | 20.7% | 17.7% | 15.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −33.0M+1% | – | – | – | −32.6M | – | – | −52.0M | – | – | – |
| 資本支出 | – | 34K | – | – | – | 0.00 | – | – | 40K | – | – | – |
| 自由現金流 | – | −33.0M+1% | – | – | – | −32.6M | – | – | −52.0M | – | – | – |
| 折舊攤銷 | 152K | 151K | 157K | 160K | 160K | 262K | 321K | 327K | 324K | 337K | 348K | 344K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -128.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −137M | –% | -1.91 | −125M |
| FY2024 | 67.4M | – | −166M | -246.0% | -2.33 | −171M |
| FY2023 | 0.00 | – | −292M | –% | -4.47 | −208M |
| FY2022 | 0.00 | – | −237M | –% | -4.48 | −166M |
| FY2021 | – | – | −159M | –% | -3.72 | −160M |
| FY2020 | – | – | −118M | –% | -4.19 | −87.6M |
| FY2019 | – | – | −45.7M | –% | -8.16 | −39.5M |